Super Fund Lookup is the ATO's external register of Self-Managed Super Funds' (SMSF) current compliance statuses. Employers can utilise this service to determine whether employer contributions qualify as superannuation guarantee payments.
Valsartan and hydrochlorothiazide is manufactured by Novartis Pharmaceuticals. Valsartan and hydrochlorothiazide is a combination of two medicines -- valsartan and hydrochlorothiazide. Valsartan is a newer type of blood pressure medicine known as an angiotensin II receptor blocker, or ARB for short.
Sacubitril/valsartan (Entresto), an angiotensin receptor-neprilysin inhibitor (ARNI), was approved by the FDA in July 2015 to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with congestive heart failure (New York Heart Association [NYHA] class II-IV) and reduced ejection fraction.